UNSPSC 85255802: Diagnosis of benign neoplasm on the adrenal gland

This classification denotes the group of activities that yields a diagnosis of Benign neoplasm on the Adrenal gland. Benign neoplasm on the Adrenal gland is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code D35.0

UNSPSC 85255802 Diagnosis of benign neoplasm on the adrenal gland (Commodity) shows minimal alignment with recent state and local procurement activity. The code's nominal scope—a specific diagnostic procedure—does not match the three most recent opportunities posted under it, which concern enterprise imaging systems, school-based special education services, and temporary clinical staffing. San Mateo Medical Center's October 2026 RFP for a Diagnostic Imaging PACS system addresses radiology infrastructure rather than a single diagnostic procedure; Birdville Independent School District's October 2026 solicitation for special education contracted services spans audiologists, speech therapists, and behavior analysts unrelated to adrenal imaging; and Santa Clara Health System's July 2026 qualification vehicle for temporary health professional staffing covers audiology, cardiology, diagnostic imaging, and therapy services broadly rather than a specific diagnosis. The code exhibits a fundamental categorization mismatch between its clinical definition and the work actually being purchased by state and local health systems and school districts.

Recent activity is concentrated in California and Texas. San Mateo County and Santa Clara County in California both posted imaging- or clinical-staffing-related opportunities in 2026, while Birdville Independent School District in northeast Texas solicited special education services. The geographic spread and issuing-body diversity (county health systems and school districts) suggest the code may be incorrectly applied to these opportunities in procurement systems; the actual procurement drivers—health system IT infrastructure, school district special services, and temporary clinical staffing—do not align with benign adrenal neoplasm diagnosis and warrant verification before pursuing vendors under this code.